Biesdorf, C., Guan, X., Siddani, S. R., Hoffman, D., Boehm, N., Medeiros, B. C., . . . Polepally, A. R. (2024). Pharmacokinetics and immunogenicity of eftozanermin alfa in subjects with previously-treated solid tumors or hematologic malignancies: Results from a phase 1 first-in-human study. Cancer Chemotherapy & Pharmacology, 93(4), 329-340.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Biesdorf, Carla, et al. "Pharmacokinetics and Immunogenicity of Eftozanermin Alfa in Subjects with Previously-treated Solid Tumors or Hematologic Malignancies: Results from a Phase 1 First-in-human Study."
Cancer Chemotherapy & Pharmacology 93, no. 4 (2024): 329-340.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Biesdorf, Carla, et al. "Pharmacokinetics and Immunogenicity of Eftozanermin Alfa in Subjects with Previously-treated Solid Tumors or Hematologic Malignancies: Results from a Phase 1 First-in-human Study."
Cancer Chemotherapy & Pharmacology, vol. 93, no. 4, 2024, pp. 329-340.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.